Atlas Trials

GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation

Clinical trial NCT01291316 · COMPLETED

Trial details

NCT number
NCT01291316
Sponsor
University Hospital, Geneva
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuropathic Pain
Start date
2010-04-01
Primary completion
2011-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.